CD4 and dermatomyositis: In an additional comparison between PJP− and PJP+ patients with similar treatment and diabetes status among the MDA5+ DM patients (Table S2), PJP occurred at a median of 2 months and at the time of a clear decrease of CD4+ T cell count and lymphocyte count.